Response of rat model of Pneumocystis carinii pneumonia to continuous infusion of deferoxamine.
The iron-chelating drug deferoxamine mesylate (DFO) is active against Pneumocystis carinii in vitro and in rat and mouse models of P. carinii pneumonia. Because DFO has a short half-life, daily divided or continuous dosage was expected to improve the dose response, as is the case with DFO treatment...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1995
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162759/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7492082/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.7.1442 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|